Demirelli Derya Selcuk, Genc Gencer, Basarir Celal Ilker, Bulut Serpil
Department of Neurology, Sisli Hamidiye Etfal Training and Research Hospital, Istanbul, Turkey.
Sisli Etfal Hastan Tıp Bul. 2022 Mar 28;56(1):55-61. doi: 10.14744/SEMB.2021.65785. eCollection 2022.
Data on the co-occurrence of stroke and coronavirus disease 2019 (COVID-19) infection are limited and need to be improved. In our study, we aimed to evaluate the clinical and laboratory characteristics of COVID-19-related patients admitted to our center with acute stroke and compare them with acute stroke patients without COVID-19 infection during the same period.
One hundred and eighty-four patients admitted with acute stroke from March 11, 2020, to May 11, 2020, were included in the study. Demographic and clinical characteristics, work-up studies, and clinical scales including National Institutes of Health Stroke Scale (NIHSS), modified Rankin scale (mRS) scores were examined retrospectively. All patients diagnosed with acute stroke who were also evaluated for COVID-19 before hospitalization were divided into two groups: COVID-19-related and unrelated cases.
COVID-19-related and unrelated acute stroke patients had similar characteristics in terms of age, gender, and stroke risk factors. The admission NIHSS (mean NIHSS: 9.8 vs. 5.9) scores and the discharge mRS values (mean mRS: 3.9 vs. 2.4) were significantly higher in the COVID-19-related stroke group (p=0.002 and p=0.001, respectively). The prognosis of the COVID-19-related stroke group was significantly worse (69.6% vs. 39.8%) and the mortality rate (39.1% vs. 6.2%) was significantly higher than the COVID-19-unrelated stroke group (p=0.007 vs. p=0.000, respectively). The proportion of patients with large infarcts in the COVID-19-related acute ischemic stroke group was significantly higher than the one in the COVID-19-unrelated acute ischemic stroke group (57.9% vs. 21.9%, p=0.003).
This is the first comparative study to evaluate the clinical presentation and outcome of COVID-19-related acute ischemic and hemorrhagic stroke patients in Turkey. Our results suggest that COVID-19-related acute stroke is associated with more severe clinical presentation and worse outcome. This seems to be linked to the coagulation abnormalities induced by COVID-19 infection.
关于中风与2019冠状病毒病(COVID-19)感染同时发生的数据有限,需要加以完善。在我们的研究中,我们旨在评估因急性中风入住我们中心的COVID-19相关患者的临床和实验室特征,并将其与同期未感染COVID-19的急性中风患者进行比较。
纳入2020年3月11日至2020年5月11日因急性中风入院的184例患者。回顾性检查人口统计学和临床特征、检查研究以及包括美国国立卫生研究院卒中量表(NIHSS)、改良Rankin量表(mRS)评分在内的临床量表。所有在住院前也接受了COVID-19评估的急性中风确诊患者被分为两组:COVID-19相关组和非相关组。
COVID-19相关和非相关急性中风患者在年龄、性别和中风危险因素方面具有相似特征。COVID-19相关中风组的入院NIHSS(平均NIHSS:9.8对5.9)评分和出院mRS值(平均mRS:3.9对2.4)显著更高(分别为p = 0.002和p = 0.001)。COVID-19相关中风组的预后明显更差(69.6%对39.8%),死亡率(39.1%对6.2%)显著高于非COVID-19相关中风组(分别为p = 0.007对p = 0.000)。COVID-19相关急性缺血性中风组中大面积梗死患者的比例显著高于非COVID-19相关急性缺血性中风组(57.9%对21.9%,p = 0.003)。
这是第一项评估土耳其COVID-19相关急性缺血性和出血性中风患者临床表现和结局的比较研究。我们的结果表明,COVID-19相关急性中风与更严重的临床表现和更差的结局相关。这似乎与COVID-19感染引起的凝血异常有关。